Two simple biomarkers could differentiate which young women with ER+ breast cancer ne

[News]

New research from Yale Cancer Center identified that two simple biomarkers, immune cells and estrogen receptor levels, could differentiate which young women with ER+ breast cancer need chemotherapy to improve their survival, and which only need a monthly injection to suppress ovarian function.

More... (https://www.news-medical.net/news/20221114/Two-simple-biomarkers-could-differentiate-which-young-women-with-ER2b-breast-cancer-need-chemotherapy.aspx)